$20.69
0.20.98%
At Close: -
$20.69
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Medifast (NYSE:MED) Stock, Analyst Ratings, Price Targets, Forecasts
Medifast Inc has a consensus price target of $83.17 based on the ratings of 3 analysts. The high is $150 issued by Jefferies on August 4, 2022. The low is $17.5 issued by DA Davidson on July 22, 2024. The 3 most-recent analyst ratings were released by DA Davidson on July 22, 2024, June 5, 2024, and April 30, 2024, respectively. With an average price target of $20 between DA Davidson, there's an implied -3.33% downside for Medifast Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
DA Davidson
Stephens & Co.
Jefferies
1calculated from analyst ratings
Analyst Ratings for Medifast
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | -15.42% | DA Davidson | Linda Bolton Weiser | $17.5 → $17.5 | Maintains | Underperform | Get Alert |
| 06/05/2024 | Buy Now | -15.42% | DA Davidson | Linda Bolton Weiser | $25 → $17.5 | Downgrade | Neutral → Underperform | Get Alert |
| 04/30/2024 | Buy Now | 20.83% | DA Davidson | Linda Bolton Weiser | $40 → $25 | Maintains | Neutral | Get Alert |
| 02/21/2024 | Buy Now | 93.33% | DA Davidson | Linda Bolton Weiser | $67 → $40 | Maintains | Neutral | Get Alert |
| 10/13/2023 | Buy Now | 296.33% | Stephens & Co. | Jim Salera | → $82 | Initiates | → Equal-Weight | Get Alert |
| 08/08/2023 | Buy Now | 286.66% | DA Davidson | Linda Bolton Weiser | $93 → $80 | Maintains | Neutral | Get Alert |
| 07/31/2023 | Buy Now | 349.49% | DA Davidson | Linda Bolton Weiser | $75 → $93 | Maintains | Neutral | Get Alert |
| 05/02/2023 | Buy Now | 243.16% | DA Davidson | Linda Bolton Weiser | $94 → $71 | Maintains | Neutral | Get Alert |
| 02/22/2023 | Buy Now | 354.33% | DA Davidson | Linda Bolton Weiser | $106 → $94 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | 412.32% | DA Davidson | Linda Bolton Weiser | $278 → $106 | Downgrade | Buy → Neutral | Get Alert |
| 08/04/2022 | Buy Now | 1243.64% | DA Davidson | Linda Bolton Weiser | $352 → $278 | Maintains | Buy | Get Alert |
| 08/04/2022 | Buy Now | 624.99% | Jefferies | Stephanie Wissink | $345 → $150 | Downgrade | Buy → Hold | Get Alert |
| 06/02/2022 | Buy Now | 1601.3% | DA Davidson | Linda Bolton Weiser | $341 → $352 | Maintains | Buy | Get Alert |
| 02/24/2022 | Buy Now | 1548.14% | DA Davidson | Linda Bolton Weiser | $349 → $341 | Maintains | Buy | Get Alert |
| 11/08/2021 | Buy Now | 1586.81% | DA Davidson | Linda Bolton Weiser | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Medifast (MED) stock?
The latest price target for Medifast (NYSE:MED) was reported by DA Davidson on July 22, 2024. The analyst firm set a price target for $17.50 expecting MED to fall to within 12 months (a possible -15.42% downside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medifast (MED)?
The latest analyst rating for Medifast (NYSE:MED) was provided by DA Davidson, and Medifast maintained their underperform rating.
When was the last upgrade for Medifast (MED)?
There is no last upgrade for Medifast
When was the last downgrade for Medifast (MED)?
The last downgrade for Medifast Inc happened on June 5, 2024 when DA Davidson changed their price target from $25 to $17.5 for Medifast Inc.
When is the next analyst rating going to be posted or updated for Medifast (MED)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medifast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medifast was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Medifast (MED) correct?
While ratings are subjective and will change, the latest Medifast (MED) rating was a maintained with a price target of $17.50 to $17.50. The current price Medifast (MED) is trading at is $20.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.